TP53 and colorectal carcinoma: Further analysis also revealed that mutant APC genotypes, in combination with mutant TP53, strongly correlated with a gene expression signature measuring cetuximab sensitivity (CTX-S), suggesting a predictive role of the 2-gene mutation signature of APC and TP53 mutations (AP) in CRC [28].